Entheon Biomedical Corp.

Research Entheon Biomedical Corp. (1XU) on Bullrun: market cap EUR 277.18K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker1XU
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 277.18K
• Financial periodQ1 2026
• Net income-EUR 99.72K
• Free cash flow-EUR 54.24K

Valuation Snapshot

latest market cap is EUR 277.18K.

About Entheon Biomedical Corp.

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Frequently asked questions

What is Entheon Biomedical Corp.'s market cap?

Entheon Biomedical Corp.'s market capitalization is EUR 277.18K.

What does Entheon Biomedical Corp. do?

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.